Newswise — LOS ANGELES — Sept. 11, 2012 – Paul W. Noble, MD, an international leader in pulmonary medicine, has been named chair of the Department of Medicine at Cedars-Sinai Medical Center.
Noble comes to Cedars-Sinai from Duke University Medical Center in Durham, N.C., where he has been professor and chief of the Division of Pulmonary, Allergy and Critical Care Medicine since 2006.
"We are pleased to welcome an outstanding clinician, scientist and educator of Dr. Noble's caliber to Cedars-Sinai," said Shlomo Melmed, MD, senior vice president for Academic Affairs and dean of the medical faculty at Cedars-Sinai. "His commitment to scholarly research resulting in improved treatments for patients is an excellent fit for our medical center's mission. Our strong Department of Medicine has long been a source of pride for Cedars-Sinai, and we are confident that the leadership reins are being placed into very capable hands."
Noble's clinical expertise and research focuses on unraveling mechanisms underlying chronic lung inflammation and idiopathic pulmonary fibrosis, and developing novel treatments for these disorders. His research is heavily supported by the National Heart, Lung and Blood Institute at the National Institutes of Health.
Noble succeeds Glenn Braunstein, MD, who is stepping down after 26 years as chair of the Department of Medicine to a new role as Vice President for Clinical Innovation, leading an institution-wide initiative at Cedars-Sinai to implement best practices for integrated, accountable, coordinated care. Under Braunstein’s astute leadership, the Department of Medicine consistently has been recognized as a national leader in patient care, research discovery and education and has attracted prominent researchers and physicians from around the nation and the world to Cedars-Sinai.
Noble is a prolific author, with his original research appearing in the highest quality peer-reviewed publications, including the New England Journal of Medicine, Science and Nature Medicine. A deputy editor of the Journal of Clinical Investigation, Noble has been a leading contributor to discovery in lung disease.
Noble, 54, who earned his bachelor’s degree at Haverford College and his medical degree from New York University School of Medicine, completed his residency and chief residency in Internal Medicine at UC San Francisco and pulmonary and critical care fellowships at the University of Colorado Health Sciences Center and the National Jewish Center for Immunology and Respiratory Medicine.
As an assistant professor of medicine at The Johns Hopkins University School of Medicine, he was founder and director of the Interstitial Lung Disease Clinic, before moving on to becoming professor of medicine and associate chief of pulmonary and critical care at Yale University School of Medicine, where he also formed an Interstitial Lung Disease Clinic. At Duke, he propelled his Division to the highest ranks in the nation for clinical care, research productivity and NIH funding.
An elected member of the American Society of Clinical Investigation and the American Association of Physicians, he has been a member of the editorial boards for the American Journal of Respiratory Cell and Molecular Biology and the American Journal of Respiratory and Critical Care Medicine. He also is a member of the scientific advisory board of the American Asthma Foundation.